The Motley Fool Podcasts Market Foolery Little Pharma On The Rise

Little Pharma On The Rise Logo

Little Pharma On The Rise

Concert Pharmaceuticals’ stock rises 80% on a deal with Vertex. Jason Moser analyzes the pharmaceutical landscape and weighs in on The New York Times’ new Twitter strategy.  Plus we dip into the Fool Mailbag and share memories of the late...

Listen to Little Pharma On The Rise

Recent Episodes

Listen
Listen
Listen
Listen
Listen
Listen
Listen
Listen
Listen
Listen

More Podcasts

Motley Fool Premium Services

Motley Fool Stock Picking Advice
Return
S&P
Stock Advisor
David and Tom Gardner's top stock recommendations
245.7%
69.69%
Rule Breakers
High-growth businesses poised to be tomorrow's market leaders
112.4%
57.49%
Income Investor
High-yielding stocks that pay out steady dividends
46.1%
42.54%
Hidden Gems
The world's best small-cap stocks
62.6%
54.34%
Inside Value
Undervalued stocks overlooked by Wall Street
48.7%
31.08%

Click the chart below to find the Motley Fool premium service that’s right for your investing style. Learn more.

Motley Fool Services Map Volatility profiles based on trailing-three-year calculations of the standard deviation of service investment returns as of July 31, 2015. Options, Pro, and Special Ops may use alternative instruments.
All returns as of each newsletter's date of origin. Recommendation Services Investment Return Calculations